Delivery Order SPE2DB22D3011-SPE2DB26FP7GV
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Cephalexin 500 mg capsules (500-count units) valued at $2,322.83. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and requires ultimate completion by August 7, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,087.30 to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a fulfillment under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,609.79 to AmerisourceBergen Drug Corp for 500 mg Cephalexin capsules (500-count units) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The performance...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,314,953 units of Cephalexin 500 mg capsules. The contract has a firm fixed price of $4,979.51 and a performance period that runs through August 2, 2024. The contract is not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up...
- The Defense Logistics Agency awarded a $1,141.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 capsules of Cephalexin 500 mg, a commonly prescribed antibiotic medication. The contract was competitively awarded without set-aside designation and is scheduled for completion by October 24, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The delivery order is for the supply of Cephalexin 500 mg capsules, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a ceiling value of $1,076.82 and a period of performance through March 11, 2024. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a division of Cencora, Inc. The contract, worth up to $1,087.66, is for the delivery of 4,564,339,528 units of Cephalexin 500 mg Capsules. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Cephalexin 500 mg capsules. The contract has a firm fixed price of $2,094.59 and a period of performance through July 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any subcontractors. The contract is not set aside and was awarded through open...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Cephalexin 500 mg capsules, a common antibiotic medication. The contract has a firm fixed price of $2,560.70 and a completion date of May 6, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Cephalexin 500 mg capsules. The contract has a firm fixed-price structure and a ceiling value of $6,526.14. It was awarded on May 2, 2024, with an ultimate completion date of May 3, 2024. The contract is not set-aside and was awarded on a full and open competition basis. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery...
- SPE2DB22D3011Indefinite Delivery Contract
- SPE2DB22D3011-SPE2DB26FP7GVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cephalexin 500 mg capsules (500-count) under a firm fixed-price contract with a ceiling value of $3,027.14. The award, issued on October 28, 2025, with an ultimate completion date of October 29, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same city. This delivery order falls under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion global pharmaceutical support vehicle extending through December 2026. The IDC enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, generic and brand-name drugs, and medical commodities across multiple therapeutic domains. The DLA utilizes this prime vendor arrangement to efficiently fulfill critical pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/28/25 |